Diabetics

Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

By the 1950s, kidney disease was clearly recognized as a common complication of diabetes, with as many as 50% of patients with diabetes of more than 20 years having this complication Currently, diabetic nephropathy is the leading cause of chronic kidney disease in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage renal disease (ESRD) cases in the United States. Generally, diabetic nephropathy is considered after a routine urinalysis and screening for micro albuminuria in the setting of diabetes. Patients may have physical findings associated with long-standing diabetes mellitus. Good evidence suggests that early treatment delays or prevents the onset of diabetic nephropathy or diabetic kidney disease. Regular outpatient follow-up is key in managing diabetic nephropathy successfully. Recently, attention has been called to atypical presentations of diabetic nephropathy with dissociation of proteinuria from reduced kidney function. Also noted is that micro albuminuria is not always predictive of diabetic nephropathy

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Contrast Nephropathy, Uric acid Nephropathy
  • Diabetic Glomerulosclerosis, IgA Nephropathy
  • Pathogenesis of Diabetic Nephropathy
  • HIV Associated Nephropathy
  • Glycemic Control, Diabetic Ketoacidosis

Related Conference of Diabetics

July 23-24, 2018

14th World Nephrology Conference

Melbourne, Australia
October 08-10, 2018

3rd World Kidney Congress

Dubai, UAE
October 15-16, 2018

22nd European Nephrology Conference

Warsaw, Poland
October 19-20, 2018

3rd Annual Kidney Congress

New York City, New York, USA
October 19-20, 2018

16th International Conference on Nephrology & Therapeutics

New York City, New York, USA
November 19-21, 2018

International Conference on Nephrology

Cape Town, South Africa
December 06-07, 2018

Annual Congress on Nephrology & Hypertension

Amsterdam, Netherlands
April 22-23, 2019

15th International Conference on Nephrology and Hypertension

Kuala Lumpur, Malaysia
June 03-04, 2019

20th Global Nephrologists Annual Meeting

London, UK
November 18-19, 2019

18th Annual Conference on Urology and Nephrological Disorders

Cape Town, South Africa

Diabetics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in